NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
9.25
-0.37 (-3.85%)
Apr 28, 2026, 4:00 PM EDT - Market closed
NextCure Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 33 | 50 | 22 | 32 | 39 | 166 | |
| Market Cap Growth | 304.10% | 130.37% | -32.12% | -18.77% | -76.37% | -44.81% | |
| Enterprise Value | -4 | 26 | -48 | -80 | -130 | -70 | |
| Last Close Price | 9.25 | 14.19 | 9.25 | 13.68 | 16.92 | 72.00 | |
| PB Ratio | 0.93 | 1.42 | 0.33 | 0.28 | 0.23 | 0.71 | |
| P/TBV Ratio | 0.94 | 1.42 | 0.33 | 0.28 | 0.23 | 0.71 | |
| Debt / Equity Ratio | 0.15 | 0.15 | 0.09 | 0.06 | 0.04 | - | |
| Net Debt / Equity Ratio | -1.05 | -1.05 | -0.96 | -0.89 | -0.91 | -0.94 | |
| Net Debt / EBITDA Ratio | 0.66 | 0.66 | 1.15 | 1.59 | 2.13 | 3.30 | |
| Net Debt / FCF Ratio | 0.74 | 0.74 | 1.52 | 1.89 | 2.73 | 3.68 | |
| Quick Ratio | 3.97 | 3.97 | 7.20 | 15.85 | 17.60 | 33.23 | |
| Current Ratio | 4.14 | 4.14 | 7.50 | 16.38 | 17.97 | 34.48 | |
| Return on Equity (ROE) | -111.23% | -111.23% | -61.87% | -44.49% | -37.28% | -26.33% | |
| Return on Assets (ROA) | -54.96% | -54.96% | -34.23% | -27.08% | -22.25% | -16.11% | |
| Return on Capital Employed (ROCE) | -145.40% | -145.40% | -80.20% | -55.80% | -43.40% | -30.00% | |
| Earnings Yield | -169.56% | -112.26% | -257.74% | -197.18% | -190.83% | -41.86% | |
| FCF Yield | -150.64% | -99.73% | -191.17% | -169.11% | -143.00% | -35.98% | |
| Buyback Yield / Dilution | -21.97% | -21.97% | -0.46% | -0.33% | -0.46% | -0.30% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.